What is Bad Blood?
The Vaping Oasis, operating under the name Bad Blood, is a specialized platform dedicated to providing comprehensive reviews and insights across the vaping spectrum. Their content encompasses e-liquids, CBD, and THC products, aiming to inform vaping enthusiasts about the latest innovations and flavor profiles. The company also supports DIY e-juice creators, guiding consumers toward informed purchasing decisions and enhancing their overall vaping experiences. With a commitment to quality and a diverse product range, The Vaping Oasis serves a broad segment of the vaping community.
How much funding has Bad Blood raised?
Bad Blood has raised a total of $89K across 1 funding round:
Debt
$89K
Debt (2021): $89K with participation from PPP
Key Investors in Bad Blood
PPP
Public-Private Partnership
What's next for Bad Blood?
With the recent influx of substantial expansion capital, Bad Blood is poised for significant growth and market penetration. The Series B/C stage funding indicates a strategic phase focused on scaling operations, potentially expanding product lines, and enhancing market reach. Future developments are likely to involve further innovation in content delivery and product curation, solidifying their position within the competitive vaping industry. This investment will fuel strategic initiatives aimed at capturing greater market share and reinforcing their brand as a trusted resource for vaping consumers.
See full Bad Blood company page